Antiretroviral treatment and research in resource-poor countries.

Lancet

Volumn 361, Issue 9355, 2003, Pages 435-

  Pawinski, Robert ^a   Bobat, Raziya ^a   Friedland, Gerald ^a   Jeena, Prakash ^a   Lalloo, Umesh ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; ECONOMICS; HEALTH; HEALTH CARE POLICY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; NOTE; ORGANIZATION AND MANAGEMENT; POVERTY; RESEARCH; UNITED NATIONS; UTILIZATION REVIEW;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; HEALTH POLICY; HUMANS; POVERTY; RESEARCH; UNITED NATIONS; WORLD HEALTH;

EID: 0037313104     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12415-4     Document Type: Note

References (0)